SofWave Overview
- Year Founded
-
2015
- Status
-
Public
- Employees
-
151
- Stock Symbol
-
SOFW
- Share Price
-
$10.95
- (As of Friday Closing)
SofWave General Information
Description
Sofwave Medical Ltd is engaged in the development, production, marketing, and sale of systems for skin rejuvenation and firming treatments. SUPERB, Synchronous Ultrasound Parallel Beam technology, is the company's FDA-cleared technology to improve facial lines and wrinkles, lift the eyebrows and lax submental tissue (beneath the chin), lift lax skin in the arms, and provide short-term improvement in the appearance of cellulite and treatment of acne scars. Its Pure Impact module uses EMS technology and is cleared for muscle toning. Sofwave's products provide physicians with effective and safe aesthetic solutions for their patients. Geographically, it generates maximum revenue from the United States, followed by East Asia, Europe and the Middle East, and other regions.
Contact Information
Website
www.sofwave.comCorporate Office
- 1 Ha-Otsma Street
- Yokneam Illit
- Israel
Corporate Office
- 1 Ha-Otsma Street
- Yokneam Illit
- Israel
SofWave Stock Performance
As of 13-Nov-2026, SofWave’s stock price is $10.95. Its current market cap is $398M with 36.4M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $10.95 | $11.32 | $8.28 - $16.77 | $398M | 36.4M | 95.3K | $0.33 |
SofWave Financials Summary
As of 30-Sep-2026, SofWave has a trailing 12-month revenue of $112M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 394,213 | 284,163 | 120,578 | 105,006 |
| Revenue | 111,775 | 87,637 | 59,651 | 50,315 |
| EBITDA | 13,458 | 6,940 | (2,895) | (7,390) |
| Net Income | 11,976 | 5,487 | (4,546) | (8,278) |
| Total Assets | 65,988 | 55,769 | 43,029 | 43,536 |
| Total Debt | 1,253 | 1,124 | 1,395 | 1,329 |
SofWave Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
SofWave Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
SofWave Comparisons
Industry
Financing
Details
SofWave Competitors (1)
One of SofWave’s competitors is Ultherapy, a Corporation company based in Raleigh, NC.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ultherapy | Corporation | Raleigh, NC |
SofWave Patents
SofWave Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-D1120866-S1 | Charging station for electronic muscle stimulator | Active | 08-Jan-2024 | ||
| US-D1084004-S1 | Display screen with graphical user interface | Active | 08-Jan-2024 | ||
| AU-2025206926-A1 | Electrical muscle stimulation | Pending | 08-Jan-2024 | ||
| WO-2025150044-A1 | Electrical muscle stimulation | Inactive | 08-Jan-2024 | ||
| US-D1121831-S1 | Electronic muscle stimulator for medical purposes | Active | 08-Jan-2024 |
SofWave Signals
SofWave ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
SofWave FAQs
-
When was SofWave founded?
SofWave was founded in 2015.
-
Where is SofWave headquartered?
SofWave is headquartered in Yokneam Illit, Israel.
-
What is the size of SofWave?
SofWave has 151 total employees.
-
What industry is SofWave in?
SofWave’s primary industry is Other Devices and Supplies.
-
Is SofWave a private or public company?
SofWave is a Public company.
-
What is SofWave’s stock symbol?
The ticker symbol for SofWave is SOFW.
-
What is the current stock price of SofWave?
As of 13-Nov-2026 the stock price of SofWave is $10.95.
-
What is the current market cap of SofWave?
The current market capitalization of SofWave is $398M.
-
What is SofWave’s current revenue?
The trailing twelve month revenue for SofWave is $112M.
-
Who are SofWave’s competitors?
Ultherapy is a competitor of SofWave.
-
What is SofWave’s annual earnings per share (EPS)?
SofWave’s EPS for 12 months was $0.33.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process